Impairment of the proteasome has been hypothesized to be a disease-causing mechanism in ALS/FTD (Scotter et al., 2015; Taylor et al., 2016); thus, many studies have examined TDP-43 cellular localization upon proteasome inhibition with MG132. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.